Nomura Holdings Inc Eli Lilly & CO Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

A detailed history of Nomura Holdings Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Nomura Holdings Inc holds 30,141 shares of LLY stock, worth $23.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

30,141

Previous 46,363 34.99%

Holding current value

$23.7 Million

Previous $42 Million 36.39%

% of portfolio

0.06%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $12.5 Million - $15.6 Million	-16,222 Reduced 34.99%	30,141 $26.7 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $15.3 Million - $19.2 Million	21,162 Added 83.97%	46,363 $42 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $14.9 Million - $20 Million	25,201 New	25,201 $19.6 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $5.71 Million - $6.73 Million	10,863 Added 222.83%	15,738 $9.17 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $4.35 Million - $6 Million	-10,012 Reduced 67.25%	4,875 $2.62 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $4.38 Million - $5.86 Million	12,489 Added 520.81%	14,887 $6.98 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $3.56 Million - $4.18 Million	-11,464 Reduced 82.7%	2,398 $823,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $4.59 Million - $5.34 Million	-14,260 Reduced 50.71%	13,862 $5.07 Million
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $8.34 Million - $9.5 Million	28,122 New	28,122 $9.1 Million
Q1 2022 May 18, 2022	SELL	$234.69 - $291.66 $2.76 Million - $3.42 Million	-11,741 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $1.63 Million - $2.02 Million	-7,253 Reduced 38.19%	11,741 $3.24 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.37 Million - $2.91 Million	10,686 Added 128.62%	18,994 $4.36 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $891,555 - $1.15 Million	4,938 Added 146.53%	8,308 $1.91 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $4.16 Million - $5.39 Million	-25,345 Reduced 88.26%	3,370 $629,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $11.3 Million - $15 Million	-86,970 Reduced 75.18%	28,715 $4.85 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $14.4 Million - $16.6 Million	98,171 Added 560.53%	115,685 $17.1 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $620,165 - $746,362	4,546 Added 35.06%	17,514 $2.88 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.54 Million - $1.91 Million	12,968 New	12,968 $1.8 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $3.46 Million - $4.29 Million	-29,089 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $2.89 Million - $3.58 Million	27,063 Added 1335.78%	29,089 $3.82 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $95,897 - $104,311	-898 Reduced 30.71%	2,026 $224,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $12,297 - $14,354	111 Added 3.95%	2,924 $329,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $5.55 Million - $6.53 Million	-49,859 Reduced 94.66%	2,813 $363,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $1.52 Million - $1.7 Million	14,325 Added 37.36%	52,672 $6.09 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $1.28 Million - $1.6 Million	14,888 Added 63.46%	38,347 $4.13 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $5.45 Million - $6.25 Million	-71,979 Reduced 75.42%	23,459 $1.65 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $5.61 Million - $6.63 Million	-75,631 Reduced 44.21%	95,438 $7.38 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $7.08 Million - $8.36 Million	95,438 Added 126.19%	171,069 $13.8 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $2.14 Million - $2.29 Million	26,086 Added 52.65%	75,631 $6.39 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.82 Million - $4.24 Million	49,545	49,545 $4.24 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Eli Lilly & CO Transaction History